FOXO1-mediated SMC apoptosis has been reported to regulate plaque instability in advanced atherosclerotic lesions, providing new ideas for AAA formation, as SMC apoptosis is a classic pathological feature of AAA (41). The gene discussed is FOXO1; the disease is triple-A syndrome.